AMG 145: Phase II data

The double-blind, international Phase II LAPLACE-TIMI 57 trial in 631 patients on a stable dose of statin therapy with or without ezetimibe showed that all doses

Read the full 261 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE